Primary Site >> Liver Cancer

Gene >> MOS

  • 1985
  • 1990
  • 1994
  • 1995
  • 2000
  • 2001
  • 2004
  • 2005
  • 2006
  • 2010
  • 2011
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Hypomethylation of c-myc and epidermal growth factor receptor genes in human hepatocellular carcinoma and fetal liver.
PMID: 3005205
 Ref: [Dependence of the therapeutic effect of hepatic artery embolization on the completeness of devascularization of liver tumor].
PMID: 2391870
 Ref: [Malignant tumors of the liver in children].
PMID: 7823468
 Ref: Biological characteristics of human hepatocellular carcinoma cell lines with or without prior nude mouse passages.
PMID: 9774996
 Ref: Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma.
PMID: 11002219
 Ref: Mechanism of up-regulated gap junctional intercellular communication during chemoprevention and chemotherapy of cancer.
PMID: 11506816
 Ref: Analysis of DNA copy number aberrations in hepatitis C virus-associated hepatocellular carcinomas by conventional CGH and array CGH.
PMID: 15133472
 Ref: Hypofractionated three-dimensional conformal radiation therapy for primary liver carcinoma.
PMID: 15812834
 Ref: Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
PMID: 16453330
 Ref: [Clinical analysis of the treatment:transcatheter arterial chemoembolization combined with sorafenib in advanced hepatocellular carcinoma].
PMID: 21029658
 Ref: Efficacy of therapy for hepatocellular carcinoma with portal vein tumor thrombus: chemoembolization and stent combined with iodine-125 seed.
PMID: 22037354
 Ref: Co-existence of hepatocellular carcinoma and hepatic tuberculosis.
PMID: 24476016
 Ref: Comparative dosing and efficacy of sorafenib in hepatocellular cancer patients with varying liver dysfunction.
PMID: 26029452
 Ref: Post-progression survival and progression-free survival in patients with advanced hepatocellular carcinoma treated by sorafenib.
PMID: 26441378
 Ref: Transarterial chemoembolization with gelatin sponge microparticles for barcelona clinic liver cancer Stage C and large hepatocellular carcinoma: Initial clinical experience.
PMID: 29237901
 Ref: FGFR3 mRNA overexpression defines a subset of oligometastatic colorectal cancers with worse prognosis.
PMID: 30181810
Ref: A Phase II and Biomarker Study of Sorafenib Combined with FOLFOX in Patients with Advanced Hepatocellular Carcinoma (HCC).
PMID: 30190369